CIZ — Cizzle Biotechnology Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- £6.54m
- £6.09m
Annual cashflow statement for Cizzle Biotechnology Holdings, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.323 | -0.832 | -0.306 | -3.96 | -0.963 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1.46 | 0 | — | 3.15 | 0.148 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.645 | 0.002 | 0.012 | -0.197 | -0.057 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.513 | -0.83 | -0.294 | -1.01 | -0.872 |
| Capital Expenditures | -0.176 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.401 | 0 | — | -0.154 | -0.12 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.225 | 0 | — | -0.154 | -0.12 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.248 | 1.21 | 0 | 2.03 | 0.595 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.04 | 0.376 | -0.294 | 0.868 | -0.397 |